PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NEFRX vs. FXNAX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


NEFRXFXNAX
YTD Return1.84%2.51%
1Y Return9.38%8.95%
3Y Return (Ann)-2.30%-2.32%
5Y Return (Ann)0.57%-0.20%
10Y Return (Ann)1.66%1.38%
Sharpe Ratio1.311.29
Sortino Ratio1.931.93
Omega Ratio1.231.23
Calmar Ratio0.540.46
Martin Ratio4.944.38
Ulcer Index1.70%1.69%
Daily Std Dev6.38%5.88%
Max Drawdown-18.76%-19.64%
Current Drawdown-7.68%-9.30%

Correlation

-0.50.00.51.00.9

The correlation between NEFRX and FXNAX is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

NEFRX vs. FXNAX - Performance Comparison

In the year-to-date period, NEFRX achieves a 1.84% return, which is significantly lower than FXNAX's 2.51% return. Over the past 10 years, NEFRX has outperformed FXNAX with an annualized return of 1.66%, while FXNAX has yielded a comparatively lower 1.38% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%2.00%4.00%6.00%8.00%JuneJulyAugustSeptemberOctoberNovember
3.72%
4.32%
NEFRX
FXNAX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


NEFRX vs. FXNAX - Expense Ratio Comparison

NEFRX has a 0.71% expense ratio, which is higher than FXNAX's 0.03% expense ratio.


NEFRX
Loomis Sayles Core Plus Bond Fund
Expense ratio chart for NEFRX: current value at 0.71% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.71%
Expense ratio chart for FXNAX: current value at 0.03% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.03%

Risk-Adjusted Performance

NEFRX vs. FXNAX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and Fidelity U.S. Bond Index Fund (FXNAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NEFRX
Sharpe ratio
The chart of Sharpe ratio for NEFRX, currently valued at 1.25, compared to the broader market0.002.004.001.25
Sortino ratio
The chart of Sortino ratio for NEFRX, currently valued at 1.82, compared to the broader market0.005.0010.001.82
Omega ratio
The chart of Omega ratio for NEFRX, currently valued at 1.22, compared to the broader market1.002.003.004.001.22
Calmar ratio
The chart of Calmar ratio for NEFRX, currently valued at 0.52, compared to the broader market0.005.0010.0015.0020.0025.000.52
Martin ratio
The chart of Martin ratio for NEFRX, currently valued at 4.53, compared to the broader market0.0020.0040.0060.0080.00100.004.53
FXNAX
Sharpe ratio
The chart of Sharpe ratio for FXNAX, currently valued at 1.29, compared to the broader market0.002.004.001.29
Sortino ratio
The chart of Sortino ratio for FXNAX, currently valued at 1.93, compared to the broader market0.005.0010.001.93
Omega ratio
The chart of Omega ratio for FXNAX, currently valued at 1.23, compared to the broader market1.002.003.004.001.23
Calmar ratio
The chart of Calmar ratio for FXNAX, currently valued at 0.46, compared to the broader market0.005.0010.0015.0020.0025.000.46
Martin ratio
The chart of Martin ratio for FXNAX, currently valued at 4.38, compared to the broader market0.0020.0040.0060.0080.00100.004.38

NEFRX vs. FXNAX - Sharpe Ratio Comparison

The current NEFRX Sharpe Ratio is 1.31, which is comparable to the FXNAX Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of NEFRX and FXNAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.25
1.29
NEFRX
FXNAX

Dividends

NEFRX vs. FXNAX - Dividend Comparison

NEFRX's dividend yield for the trailing twelve months is around 3.94%, more than FXNAX's 3.29% yield.


TTM20232022202120202019201820172016201520142013
NEFRX
Loomis Sayles Core Plus Bond Fund
3.94%3.59%3.09%2.14%2.04%2.52%2.88%2.68%3.18%2.59%3.26%4.06%
FXNAX
Fidelity U.S. Bond Index Fund
3.29%2.92%2.41%1.81%2.10%2.69%2.74%2.52%2.52%2.69%2.59%2.39%

Drawdowns

NEFRX vs. FXNAX - Drawdown Comparison

The maximum NEFRX drawdown since its inception was -18.76%, roughly equal to the maximum FXNAX drawdown of -19.64%. Use the drawdown chart below to compare losses from any high point for NEFRX and FXNAX. For additional features, visit the drawdowns tool.


-14.00%-12.00%-10.00%-8.00%-6.00%-4.00%JuneJulyAugustSeptemberOctoberNovember
-7.68%
-9.30%
NEFRX
FXNAX

Volatility

NEFRX vs. FXNAX - Volatility Comparison

Loomis Sayles Core Plus Bond Fund (NEFRX) has a higher volatility of 1.74% compared to Fidelity U.S. Bond Index Fund (FXNAX) at 1.63%. This indicates that NEFRX's price experiences larger fluctuations and is considered to be riskier than FXNAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


1.00%1.20%1.40%1.60%1.80%2.00%JuneJulyAugustSeptemberOctoberNovember
1.74%
1.63%
NEFRX
FXNAX